chr17-18171676-G-A
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_016239.4(MYO15A):c.10121G>A(p.Arg3374His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000731 in 1,613,784 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_016239.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYO15A | NM_016239.4 | c.10121G>A | p.Arg3374His | missense_variant | 63/66 | ENST00000647165.2 | NP_057323.3 | |
MYO15A | XM_017024715.3 | c.10124G>A | p.Arg3375His | missense_variant | 61/64 | XP_016880204.1 | ||
MYO15A | XM_017024714.3 | c.10061G>A | p.Arg3354His | missense_variant | 60/63 | XP_016880203.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYO15A | ENST00000647165.2 | c.10121G>A | p.Arg3374His | missense_variant | 63/66 | NM_016239.4 | ENSP00000495481 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000283 AC: 43AN: 152144Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000137 AC: 34AN: 249024Hom.: 1 AF XY: 0.000118 AC XY: 16AN XY: 135232
GnomAD4 exome AF: 0.0000513 AC: 75AN: 1461522Hom.: 0 Cov.: 32 AF XY: 0.0000564 AC XY: 41AN XY: 727078
GnomAD4 genome AF: 0.000282 AC: 43AN: 152262Hom.: 1 Cov.: 32 AF XY: 0.000255 AC XY: 19AN XY: 74438
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Athena Diagnostics | Aug 31, 2018 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 15, 2024 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Aug 11, 2015 | p.Arg3374His in exon 63 of MYO15A: This variant is not expected to have clinical significance due to a lack of conservation across species, including mammals. O f note, >10 mammals have a histidine (His) at this position despite high nearby amino acid sequence conservation. In addition, computational prediction tools d o not suggest a high likelihood of impact to the protein. It has been identified in 0.13% (12/9514) of African chromosomes by the Exome Aggregation Consortium ( ExAC, http://exac.broadinstitute.org; dbSNP rs201794696). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at